The FINANCIAL -- CSL Behring, one of the global leaders in the plasma-protein biotherapeutics industry, is calling for grant requests through its Local Empowerment for Advocacy Development (LEAD) program.

The FINANCIAL -- Baxter International Inc. (NYSE: BAX) on October 7 confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology.

The FINANCIAL -- Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP) announced on October 6 that the European Commission has approved SIMPONI (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderate-to-severe, active rheumatoid arthritis (RA), active and progressive psoriatic arthritis (PsA) and severe, active ankylosing spondylitis (AS).

The FINANCIAL -- GlaxoSmithKline (GSK) and Jiangsu Walvax Biotech Company (Walvax) on October 6 announced a cooperation agreement to form a long-term Joint Venture (JV) to develop and manufacture paediatric vaccines for use in China.

The FINANCIAL -- Schering-Plough Corp. (NYSE: SGP) announced on October 5 that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.